Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,623 | 1,146 | 990 | 1,105 | 1,256 |
| Receivables | 858 | N/A | 997 | 1,057 | 1,354 |
| Inventories | 756 | N/A | 798 | 763 | 655 |
| Other current assets | 288 | 1,922 | 168 | 171 | 138 |
| TOTAL | $3,524 | $3,069 | $2,953 | $3,097 | $3,403 |
| Non-Current Assets | |||||
| PPE Net | 1,209 | N/A | 1,243 | 1,252 | 1,303 |
| Intangibles | 810 | N/A | 817 | 826 | 835 |
| Other Non-Current Assets | 467 | 2,514 | 452 | 444 | 1,054 |
| TOTAL | $2,487 | $2,514 | $2,512 | $2,523 | $3,192 |
| Total Assets | $6,011 | $5,582 | $5,465 | $5,620 | $6,595 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,794 | N/A | 5,314 | 4,174 | 4,241 |
| Accounts payable and accrued liabilities | 373 | N/A | 543 | 603 | 413 |
| Accrued Expenses | 1,357 | N/A | 1,410 | 1,245 | 1,660 |
| TOTAL | $9,633 | $8,257 | $7,589 | $6,342 | $6,633 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,389 | N/A | 1,552 | 1,595 | 1,391 |
| Deferred Revenues | 993 | N/A | 208 | 208 | 208 |
| Other Non-Current Liabilities | -2,179 | 3,571 | -2,341 | -2,385 | -2,353 |
| TOTAL | $3,391 | $3,571 | $3,294 | $3,416 | $3,291 |
| Total Liabilities | $13,024 | $11,828 | $10,883 | $9,758 | $9,923 |
| Shareholders' Equity | |||||
| Common Shares | 23,686 | N/A | 23,136 | 23,133 | 23,133 |
| Retained earnings | -40,552 | N/A | -38,301 | -37,100 | -36,230 |
| Other shareholders' equity | 139 | -8,587 | 0 | 0 | 0 |
| TOTAL | $-9,192 | $-8,587 | $-7,759 | $-6,523 | $-5,682 |
| Total Liabilities And Equity | $3,832 | $3,241 | $3,124 | $3,235 | $4,242 |